EMPLOYMENT

Nov 2021 -                 Professor (full, tenured) at ILF/UCPH

Jan 2013 –  Oct 2021  Associate Professor (tenured) at ILF/UCPH

Apr 2015 – Jun 2015   Visiting Prof., Dept. of Chemistry, Uni. of Oxford, UK

Oct 2006 – Dec 2012  Associate Professor (external funding) at ILF/UCPH

Mar 2003 – Sep 2006 Assistant Professor (external funding) at ILF/UCPH

Mar 2002 – Feb 2003 Postdoc, Department of Chemistry, DTU

Sep 1998 – Feb 2002    Ph.D. in organic chemistry/medicinal chemistry, KU 

Aug 1996 – Aug 1998    M.Sc. in organic chemistry, Florida State University, USA 

Jan 1992 – Jul 1996      B.Sc. in Chemical Engineering, DTU, Denmark

Jun 2007 – Dec 2007     Leadership in research environments, CBS

Aug 2006 – Aug 2007    Higher Education Teaching and Teaching Practice, KU

Apr 2021 –                      Leader of Center for Medicinal Chemistry at UCPH

Apr 2019 –                      Head of Medicinal Chemistry Discipline at ILF/UCPH

Apr 2019 –                      Member of the educational committee at ILF/UCPH

Apr 2019 –                      Member of the (new) teaching committee at ILF/UCPH

Apr 2019 –                      Head of teaching in chemistry and medchem at ILF/UCPH

Jan 2016 – Mar 2019     Member of the teaching committee at ILF/UCPH

Nov 2011 – Jun 2014     President of Danish Society of Pharm., Toxicol. and Medchem (DSFTM)

May 2008 – Oct 2011    Member of the board of DSFTM and head of the MedChem section

May 2008 – Jun 2014    Member of the council of Eur. Fed. of Medicinal Chemistry (EFMC homepage)

Apr 2007 – Dec 2010     Vice-coordinator of research network: Brain-Mind-Medicines (BMM) at UCPH

Aug 1999 – Jan 2002      Elected member of the PhD study board, DFU

Feb 1999 – Aug 2000     Elected member of the board at Department of Medicinal Chemistry, DFU

Ever since my first experience with organic chemistry as an undergraduate, I have been spellbound with this field of research: The ability of mankind to synthesize any compound of interest and hereafter investigate how a structural change affects its biological activity. The intellectual aspect of rational drug design and synthesis is to me captivating and motivates me every day I go to work.

My passion for natural science made it easy for me to choose my undergraduate studies as a chemical engineer with special focus on organic synthesis and quantum chemistry. My eager to learn more and understand the fundamentals of organic chemistry drove me to pursue a 2-year master study at Florida State University (FSU) in the USA. Accepting an offer of full tuition-waiver and a teaching position at FSU, those two years of intensive study made it clear to me that I wanted to establish a research group in academia within the field of organic and medicinal chemistry.

Returning to my home country for a PhD study in organic chemistry/medicinal chemistry was an easy choice for me. The topic of my thesis was new ligands for the glutamat receptors - a fascinating field within CNS research! Changing my focus for a while, I chose to do my postdoc at DTU in Denmark within organometallic chemistry developing new methodology.

My determinacy to pursue an academic career prompted me to apply for a three-year Assistant Professorship through the Danish Research Foundation, and was granted this in 2003 within the field of glutamatergic neurotransmission.

In 2006, I was promoted to Associate Professor and established my my own research group. We focus on development of new methodology relevant for medicinal chemistry as well as discover novel tool compounds for elucidating disease mechanisms in the CNS.

BUNCH group page